Clinical and molecular epidemiology of haemophilus influenzae causing invasive disease in adult patients

PLoS One. 2014 Nov 7;9(11):e112711. doi: 10.1371/journal.pone.0112711. eCollection 2014.

Abstract

Objectives: The epidemiology of invasive Haemophilus influenzae (Hi) has changed since the introduction of the Hi type b (Hib) vaccine. The aim of this study was to analyze the clinical and molecular epidemiology of Hi invasive disease in adults.

Methods: Clinical data of the 82 patients with Hi invasive infections were analyzed. Antimicrobial susceptibility, serotyping, and genotyping were studied (2008-2013).

Results: Men accounted for 63.4% of patients (whose mean age was 64.3 years). The most frequent comorbidities were immunosuppressive therapy (34.1%), malignancy (31.7%), diabetes, and COPD (both 22%). The 30-day mortality rate was 20.7%. The majority of the strains (84.3%) were nontypeable (NTHi) and serotype f was the most prevalent serotype in the capsulated strains. The highest antimicrobial resistance was for cotrimoxazole (27.1%) and ampicillin (14.3%). Twenty-three isolates (32.9%) had amino acid changes in the PBP3 involved in resistance. Capsulated strains were clonal and belonged to clonal complexes 6 (serotype b), 124 (serotype f), and 18 (serotype e), whereas NTHi were genetically diverse.

Conclusions: Invasive Hi disease occurred mainly in elderly and those with underlying conditions, and it was associated with a high mortality rate. NTHi were the most common cause of invasive disease and showed high genetic diversity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology
  • Comorbidity
  • Diabetes Mellitus / epidemiology*
  • Female
  • Genotype
  • Haemophilus Infections / epidemiology*
  • Haemophilus Infections / microbiology
  • Haemophilus influenzae / classification
  • Haemophilus influenzae / drug effects
  • Haemophilus influenzae / genetics*
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Molecular Epidemiology
  • Molecular Typing / methods
  • Pulmonary Disease, Chronic Obstructive / epidemiology*
  • Serotyping / methods
  • Spain / epidemiology
  • Young Adult

Substances

  • Anti-Bacterial Agents

Grants and funding

Funding was provided by Fondo de Investigaciones Sanitarias de la Seguridad Social (PI0901904), and by CIBER de Enfermedades Respiratorias (CIBERES - CB06/06/0037), run by the ISCIII (Instituto de Salud Carlos III, Madrid, Spain). CP was supported by an FPU Grant AP2010-3202 (Formación de Profesorado Universitario, Ministerio de Educación, Spain). SM was supported by “Sara Borrell postdoctoral contract CD10/00298” from the Instituto de Salud Carlos III (ISCIII), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.